Andrea Kramer
About Andrea Kramer
Andrea Anigati Kramer (age 57) is Hamilton Lane’s Chief Operating Officer and Chief Risk Officer since 2023, leading client solutions, technology, operations, and risk; she joined Hamilton Lane Advisors in 2005, became Managing Director in 2010, and was appointed COO effective May 8, 2023. She holds a B.A. in Economics from Franklin & Marshall College and an M.B.A. in Finance from Temple University . Company pay-versus-performance disclosures identify Fee Related Earnings, Adjusted EBITDA, and Revenues as the most important performance measures used to link NEO compensation to performance, and HLNE’s 5-year TSR measured on a $100 investment reached $294.21 in FY2025 versus $256.43 for the peer index .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Hamilton Lane Advisors (HLA) | Managing Director | 2010–May 2023 | Oversight/management of client solutions and global primary fund investment teams; member of various investment committees . |
| Hamilton Lane Incorporated | Chief Operating Officer | May 2023–present | Leads client solutions, technology, operations, and risk functions . |
| HLA | Interim Chief Risk Officer | Apr 19, 2023 | Interim CRO duty preceding formal CRO responsibilities . |
| Exelon Capital Partners | General Partner | 1999–2002 | Diligence, technical and market analysis; negotiations; deal structuring; management of corporate-sponsored PE portfolio . |
| Philadelphia Gas Works | Senior Business Development Manager | — | Business development responsibilities (years not disclosed) . |
| Murex Corporation | Fund Manager | — | Fund management responsibilities (years not disclosed) . |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| Hamilton Lane Alliance Holdings I, Inc. (SPAC) | Chief Executive Officer & Director | 2020–2022 | HLA-sponsored SPAC; deregistered in 2022 . |
| Fund Advisory Boards | Member | — | Served on a number of fund advisory boards (various) . |
Fixed Compensation
Summary compensation (actuals):
| Metric | FY 2024 | FY 2025 |
|---|---|---|
| Base Salary ($) | 325,001 | 325,001 |
| Cash Bonus ($) | 924,125 | 1,050,000 |
| Stock Awards ($) | 362,980 | 2,098,221 |
| All Other Compensation ($) | 562,321 | 1,369,115 |
| Total ($) | 2,174,427 | 4,842,337 |
- Bonus program is discretionary and influenced by company financial performance and individual area goals; a portion for highly compensated employees is paid in time-based restricted stock, sized using a 20-day VWAP and with equity mix tiers up to 30% for bonuses ≥$500k .
- FY2025 equity portion of annual bonus (time-based restricted stock): 3,001 shares granted 3/14/2025; grant-date fair value $400,333; vests 25% annually over four years .
Performance Compensation
Equity grants and award structure:
| Type | Grant Date | Board Approval | Shares (#) | Grant-Date Fair Value ($) | Vesting |
|---|---|---|---|---|---|
| Performance Award (stock-price goals) | 9/16/2024 | 9/5/2024 | Target 5,435; Threshold 1,812; Max 5,435 | 710,608 | Vests 1/3 at each HLNE price hurdle ($150, $190, $230 avg close over 20 consecutive trading days) within 7 years, subject to continued employment and minimum 5-year service; vesting date is 5th anniversary if met earlier, otherwise when target reached . |
| Time-based Restricted Stock | 9/16/2024 | 9/5/2024 | 6,683 | 987,280 | 25% annually over 4 anniversaries . |
| Time-based Restricted Stock (annual bonus equity) | 3/14/2025 | 3/11/2025 | 3,001 | 400,333 | 25% annually over 4 anniversaries . |
Performance metrics used by HLNE to link CAP to performance (company-selected measures):
| Measure |
|---|
| Fee Related Earnings (FRE) |
| Adjusted EBITDA |
| Revenues |
Stock vested in FY2025:
| Shares Vested (#) | Value Realized ($) |
|---|---|
| 3,714 | 516,283 |
Equity Ownership & Alignment
Beneficial ownership (record date July 9, 2025):
| Class A Shares | Class B Shares | % Voting Power | % Economic Interest | Record Date |
|---|---|---|---|---|
| 295,789 | 135,970 | <1% (“*”) | <1% (“*”) | July 9, 2025 |
Outstanding equity awards at FY2025 year-end (market value at $148.67 close):
| Award Type | Grant Date | Unvested Shares (#) | Market Value ($) | Unearned Perf. Shares (#) | Market/Payout Value ($) |
|---|---|---|---|---|---|
| Time-based RS | 3/14/2022 | 881 | 130,978 | — | — |
| 2022 Performance Award | 9/16/2022 | 8,696 | 1,292,834 | 4,348 | 646,417 |
| Time-based RS | 3/14/2023 | 2,779 | 413,154 | — | — |
| Time-based RS | 3/14/2024 | 2,649 | 393,827 | — | — |
| 2024 Performance Award | 9/16/2024 | 3,624 | 538,780 | 1,811 | 269,241 |
| Time-based RS | 9/16/2024 | 6,683 | 993,562 | — | — |
| Time-based RS | 3/14/2025 | 3,001 | 446,159 | — | — |
Alignment safeguards and pressures:
- No stock options are currently granted; equity awards are restricted stock and performance stock; if options were ever granted, exercise price must be ≥ market close on grant date; no backdating practices .
- Hedging and pledging of company securities are prohibited for directors, officers, and employees (reduces misalignment risk) .
- Clawback: Policy compliant with Rule 10D-1; recovers incentive-based comp tied to erroneous financials over prior 3 years upon required restatement .
Employment Terms
- No employment, severance, or change-in-control agreement for Kramer; equity acceleration governed by the 2017 Equity Plan (Mr. Delgado-Moreira only has an employment agreement among NEOs) .
- Non-compete: Awards recipients not otherwise subject to non-competes agree to a six-month non-compete if they leave voluntarily without good reason; customary non-disclosure covenants apply .
- Change-in-control economics (double trigger if awards continued/assumed and involuntary termination without cause within 24 months, or if awards not continued/assumed): time-based and performance stock become fully vested and performance objectives deemed satisfied at target; estimated accelerated vesting value for Kramer would have been $5,124,952 at 3/31/2025 .
- Termination (not in connection with change-in-control): death/disability accelerates unvested time-based RS; performance awards forfeited; Kramer would have realized $2,377,679 on 3/31/2025 in such scenario .
- Carried Interest Plan: awards vest annually over five years; payouts depend on fund performance; subject to clawback/return obligations to funds; committee can amend/terminate plan; awards to NEOs approved by comp committee then board .
Related Party & Other Compensation
- “All Other Compensation” for FY2025 includes carried interest payments of $1,358,615 and 401(k) contributions of $10,500 .
- Tax Receivable Agreement payments to Kramer totaled $145,958 in FY2025 (routine under TRA; no audit committee approval required per policy) .
Compensation Committee & Governance Signals
- 2024 say-on-pay approval: 94.9% of votes cast supported NEO compensation .
- Committee held three meetings in FY2025; advised by Semler Brossy; no conflicts; no benchmarking used in FY2025; equity plan updated and charter revisions considered .
- Equity Compensation Plan: 6,051,701 shares available under 2017 Equity Plan and 827,935 under ESPP as of 3/31/2025 .
Investment Implications
- Alignment: Significant unvested time-based and performance equity, prohibition on hedging/pledging, and clawback policy reinforce alignment; performance awards tied to material stock price hurdles with a five-year service minimum create retention hooks and incentivize long-term value creation .
- Retention risk and selling pressure: Four-year RS schedules and performance awards with multi-year windows imply steady vesting cadence; FY2025 vested 3,714 shares suggests ongoing tax/withholding-related sales could occur around vest dates, but no pledging/hedging reduces forced-sale risk .
- Change-in-control exposure: Double-trigger acceleration and target-level vesting could materially increase realized comp upon a transaction ($5.1M indicated), a consideration for event-driven scenarios .
- Pay-for-performance context: Company emphasizes FRE, Adjusted EBITDA, and Revenues in linking pay to performance; TSR outperformance vs peer index over the measured period supports the equity-heavy structure’s alignment thesis .